Free Trial

Vera Therapeutics (VERA) Insider Trading & Ownership

Vera Therapeutics logo
$21.64 -0.65 (-2.92%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$22.06 +0.42 (+1.94%)
As of 08/29/2025 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vera Therapeutics (NASDAQ:VERA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.30%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$5.28M
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$6.11M
Get VERA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VERA Insider Buying and Selling by Quarter

Vera Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/24/2025Patrick G EnrightDirectorBuy40,607$22.35$907,566.45  
6/23/2025Patrick G EnrightDirectorBuy209,393$20.87$4,370,031.91  
1/8/2025Marshall FordyceCEOSell17,500$41.74$730,450.00  
12/18/2024Marshall FordyceCEOSell17,500$43.07$753,725.00  
12/11/2024Marshall FordyceCEOSell17,500$46.94$821,450.00  
10/28/2024Beth C SeidenbergDirectorSell15,000$48.03$720,450.00  
10/23/2024Marshall FordyceCEOSell19,375$40.39$782,556.25  
10/9/2024Marshall FordyceCEOSell15,625$38.24$597,500.00  
9/25/2024Marshall FordyceCEOSell23,125$46.05$1,064,906.25  
9/18/2024Beth C SeidenbergDirectorSell1,177$42.01$49,445.77  
9/11/2024Marshall FordyceCEOSell15,625$37.50$585,937.50  
(Data available from 1/1/2013 forward)

VERA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Vera Therapeutics includes Beth C Seidenberg, Celia Lin, Commodore Capital Lp, Joanne Curley, Joseph R Young, Maha Katabi, Marshall Fordyce, Patrick G Enright, Sean Grant, and Sofinnova Venture Partners X,. Learn more on insiders at VERA.

16.30% of Vera Therapeutics stock is owned by insiders. Learn more on VERA's insider holdings.

The following insiders have purchased VERA shares in the last 24 months: Maha Katabi ($4,999,990.00), and Patrick G Enright ($5,277,598.36).

Insiders have purchased a total of 411,290 VERA shares in the last 24 months for a total of $10,277,588.36 bought.

The following insiders have sold VERA shares in the last 24 months: Beth C Seidenberg ($769,895.77), Commodore Capital Lp ($18,900,000.00), Joseph R Young ($228,560.00), Maha Katabi ($17,350,597.80), Marshall Fordyce ($5,911,891.96), and Sean Grant ($3,954,187.08).

Insiders have sold a total of 1,733,449 Vera Therapeutics shares in the last 24 months for a total of $47,115,132.61 sold.

Vera Therapeutics Key Executives



This page (NASDAQ:VERA) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners